Substrate-Induced Trafficking of the Dopamine Transporter in Heterologously Expressing Cells and in Rat Striatal Synaptosomal Preparations

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 729-736

  Chi, Limen ^a   Reith, Maarten E A ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; DOPAMINE; DOPAMINE TRANSPORTER; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; BRAIN SYNAPTOSOME; BRAIN TISSUE; CELL HETEROGENEITY; CELL SURFACE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOWN REGULATION; ENDOCYTOSIS; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REDUCTION; STRIATE CORTEX; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; BIOTINYLATION; CELL LINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 0142148146     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.055095     Document Type: Article

References (54)

1. Apparsundaram S, Schroeter S, Giovanetti E, and Blakely RD (1998) Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther 287:744-751.
2. Beckman ML, Bernstein EM, and Quick MW (1998) Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J Neurosci 18:6103-6112.
3. Beckman ML, Bernstein EM, and Quick MW (1999) Multiple G protein-coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons. J Neurosci 19:RC9.
4. Bernstein EM and Quick MW (1999) Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA. J Biol Chem 274:889-895.
5. Bledi Y, Domb AJ, and Linial M (2000) Culturing neuronal cells on surfaces coated by a novel polyethyleneimine-based polymer. Brain Res 5:282-289.
6. Bungay PM, Newton-Vinson P, Isele W, Garris PA, and Justice JB (2003) Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem 86:932-946.
7. Chang MY, Lee SH, Kim JH, Lee KH, Kim YS, Son H, and Lee YS (2001) Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein. J Neurochem 77:754-761.
8. Chen N, Sun L, and Reith ME (2002) Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. J Neurochem 81:1383-1393.
9. Chen N, Vaughan RA, and Reith MEA (2001) The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. J Neurochem 77:1116-1127.
10. Corey JL, Davidson N, Lester HA, Brecha N, and Quick MW (1994) Protein kinase C modulates the activity of a cloned gamma-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J Biol Chem 269:14759-14767.
11. Cowell RM, Kantor L, Hewlett GH, Frey KA, and Gnegy ME (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur J Pharmacol 389:59-65.
12. Daniels GM and Amara SG (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794-35801.
13. Daws LC, Callaghan PD, Moron JA, Kahlig KM, Shippenberg TS, Javitch JA, and Galli A (2002) Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290:1545-1550.
14. Deken SL, Fremeau RTJ, and Quick MW (2002) Family of sodium-coupled transporters for GABA, glycine, proline, betaine, taurine, and creatine: pharmacology, physiology, and regulation, in Neurotransmitter Transporters: Structure, Function and Regulation (Reith MEA ed) pp 193-234, Humana Press, Totowa, NJ.
15. Duan S, Anderson CM, Stein BA, and Swanson RA (1999) Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 19:10193-10200.
16. Granas C, Ferrer J, Loland CJ, Javitch JA, and Gether U (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J Biol Chem 278:4990-5000.
17. Gulley JM, Doolen S, and Zahniser NR (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83:400-411.
18. Huff RA, Vaughan RA, Kuhar MJ, and Uhl GR (1997) Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax. J Neurochem 68:225-232.
19. Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571-591.
20. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, and von Zastrow M (1998) mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
21. Kitayama S, Dohi T, and Uhl GR (1994) Phorbol esters alter functions of the expressed dopamine transporter. Eur J Pharmacol 268:115-119.
22. Koenig JA and Edwardson JM (1997) Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol Sci 18:276-287.
23. Koenig JA, Edwardson JM, and Humphrey PP (1997) Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br J Pharmacol 120:52-59.
24. Kuczenski R and Segal DS (1992) Differential effects of amphetamine and fopamine uptake blockers (cocaine, nomifensine) on causdate and accumbens dialysate dopamine and 3-methoxytyramine. J Pharmacol Exp Ther 262:1085-1094.
25. Kuhar MJ and Pilotte NS (1996) Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 17:260-264.
26. Li LB, Cui XN, and Reith MA (2002) Is Na(+) required for the binding of dopamine, amphetamine, tyramine and octopamine to the human dopamine transporter? Naunyn-Schmiedeberg's Arch Pharmacol 365:303-311.
27. Little KY, Elmer LW, Zhong H, Scheys JO, and Zhang L (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61:436-445.
28. Loder MK and Melikian HE (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168-22174.
29. Melikian HE and Buckley KM (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19:7699-7710.
30. Missale C, Castelletti L, Govoni S, Spano PF, Trabucchi M, and Hanbauer I (1985) Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J Neurochem 45:51-56.
31. +-dependent glutamate transport activity. Neurochem Int 37:147-162.
32. Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, and Niznik HB (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30:79-87.
33. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, and Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
34. Quick MW, Corey JL, Davidson N, and Lester HA (1997) Second messengers, trafficking-related proteins and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J Neurosci 17:2967-2979.
35. Rabinovic AD, Lewis DA, and Hastings TG (2000) Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101:67-76.
36. Ramamoorthy S and Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science (Wash DC) 285:763-766.
37. Reith MEA, Berfield JL, Wang LC, Ferrer JV, and Javitch JA (2001) The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276:29012-29018.
38. Reith MEA, Xu C, and Chen N (1997) Pharmacology and regulation of the neuronal dopamine transporter. Eur J Pharmacol 324:1-10.
39. Reith MEA, Xu C, Zhang L, and Coffey LL (1996) Translocation of dopamine and binding of WIN 35, 428 measured under identical conditions in cells expressing the cloned human dopamine transporter. Naunyn-Schmiedeberg's Arch Pharmacol 354:295-304.
40. Robinson MB (2002) Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J Neurochem 80:1-11.
41. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, and Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850-6855.
42. Seamans K, Seeburg DP, Yao WD, Torres GE, and Caron MG (2001) Rapid up-regulation of dopamine uptake activity by extracellular dopamine. Soc Neurosci Abstr 27:709.20.
43. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, and Malinow R (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (Wash DC) 284:1811-1816.
44. Sibley DR, Strasser RH, Benovic JL, Daniel K, and Lefkowitz RJ (1986) Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc Natl Acad Sci USA 83:9408-9412.
45. Toews ML, Waldo GL, Harden TK, and Perkins JP (1984) Relationship between an altered membrane form and a low affinity form of the beta-adrenergic receptor occurring during catecholamine-induced desensitization. Evidence for receptor internalization. J Biol Chem 259:11844-11850.
46. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, and Caron MG (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278:2731-2739.
47. Tsao PI and von Zastrow M (2000) Type-specific sorting of G protein-coupled receptors after endocytosis. J Biol Chem 275:11130-11140.
48. Vaughan RA, Huff RA, Uhl GR, and Kuhar MJ (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem 272:15541-15546.
49. Vrindavanam NS, Arnaud P, Ma JX, Altman-Hamamdzic S, Parratto NP, and Sallee FR (1996) The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter. Neurosci Lett 216:133-136.
50. Xu C, Coffey LL, and Reith MEA (1995) Translocation of dopamine and binding of 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Biochem Pharmacol 49:339-350.
51. Zahniser NR and Doolen S (2001) Chronic and acute regulation of Na+/Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors and signaling systems. Pharmacol Ther 92:21-55.
52. Zhang L, Coffey LL, and Reith ME (1997) Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem Pharmacol 53:677-688.
53. Zhu MY, Shamburger S, Li J, and Ordway GA (2000) Regulation of the human norepinephrine transporter by cocaine and amphetamine. J Pharmacol Exp Ther 295:951-959.
54. Zhu S-J, Kavanaugh MP, Sonders MS, Amara SG, and Zahniser NR (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther 282:1358-1365.